These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes. Mullegama SV; Pugliesi L; Burns B; Shah Z; Tahir R; Gu Y; Nelson DL; Elsea SH Eur J Hum Genet; 2015 Jun; 23(6):781-9. PubMed ID: 25271084 [TBL] [Abstract][Full Text] [Related]
3. A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex. Trickett J; Heald M; Oliver C; Richards C J Neurodev Disord; 2018 Mar; 10(1):9. PubMed ID: 29490614 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder. Mullegama SV; Alaimo JT; Chen L; Elsea SH Int J Mol Sci; 2015 Apr; 16(4):7627-43. PubMed ID: 25853262 [TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour motor activity and body temperature patterns suggest altered central circadian timekeeping in Smith-Magenis syndrome, a neurodevelopmental disorder. Smith ACM; Morse RS; Introne W; Duncan WC Am J Med Genet A; 2019 Feb; 179(2):224-236. PubMed ID: 30690916 [TBL] [Abstract][Full Text] [Related]
6. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome. Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055 [TBL] [Abstract][Full Text] [Related]
7. Behavioural and psychological characteristics in Pitt-Hopkins syndrome: a comparison with Angelman and Cornelia de Lange syndromes. Watkins A; Bissell S; Moss J; Oliver C; Clayton-Smith J; Haye L; Heald M; Welham A J Neurodev Disord; 2019 Oct; 11(1):24. PubMed ID: 31586495 [TBL] [Abstract][Full Text] [Related]
8. [The sleep in children with neurodevelopmental disorders]. Pin Arboledas G Medicina (B Aires); 2019; 79(Suppl 1):44-50. PubMed ID: 30776279 [TBL] [Abstract][Full Text] [Related]
9. Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review. Korteling D; Musch JLI; Zinkstok JR; Boot E Am J Med Genet B Neuropsychiatr Genet; 2024 Mar; 195(2):e32956. PubMed ID: 37584268 [TBL] [Abstract][Full Text] [Related]
10. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome. Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403 [TBL] [Abstract][Full Text] [Related]
11. Management of Sleep Disturbances Associated with Smith-Magenis Syndrome. Kaplan KA; Elsea SH; Potocki L CNS Drugs; 2020 Jul; 34(7):723-730. PubMed ID: 32495322 [TBL] [Abstract][Full Text] [Related]
12. Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort. Rive Le Gouard N; Jacquinet A; Ruaud L; Deleersnyder H; Ageorges F; Gallard J; Lacombe D; Odent S; Mikaty M; Manouvrier-Hanu S; Ghoumid J; Geneviève D; Lehman N; Philip N; Edery P; Héron D; Rastel C; Chancenotte S; Thauvin-Robinet C; Faivre L; Perrin L; Verloes A Clin Genet; 2021 Apr; 99(4):519-528. PubMed ID: 33368193 [TBL] [Abstract][Full Text] [Related]
13. Sleep disturbances and behavior in Smith-Magenis syndrome. Garayzábal E; Hidalgo I; Miranda de Souza ALD; da Silva NC; Giacheti CM; Pinato L Res Dev Disabil; 2022 Sep; 128():104286. PubMed ID: 35779287 [TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis of MBD5-associated neurodevelopmental disorder (MAND) neural progenitor cells reveals dysregulation of autism-associated genes. Mullegama SV; Klein SD; Williams SR; Innis JW; Probst FJ; Haldeman-Englert C; Martinez-Agosto JA; Yang Y; Tian Y; Elsea SH; Ezashi T Sci Rep; 2021 May; 11(1):11295. PubMed ID: 34050248 [TBL] [Abstract][Full Text] [Related]
15. Children with neurodevelopmental disorders: how do they sleep? Belli A; Breda M; Di Maggio C; Esposito D; Marcucci L; Bruni O Curr Opin Psychiatry; 2022 Sep; 35(5):345-351. PubMed ID: 35165244 [TBL] [Abstract][Full Text] [Related]
16. Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome. Chen HY; Bohlen JF; Maher BJ Dev Neurosci; 2021; 43(3-4):159-167. PubMed ID: 34134113 [TBL] [Abstract][Full Text] [Related]
17. Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome. Sripathy SR; Wang Y; Moses RL; Fatemi A; Batista DA; Maher BJ Stem Cell Res; 2020 Oct; 48():102001. PubMed ID: 32971458 [TBL] [Abstract][Full Text] [Related]
18. A case of Pitt-Hopkins syndrome: psychopharmacological approach for anxiety, insomnia, and agitation. Istanbullu C; Kayan Ocakoglu B; Karacetin G Neurocase; 2023 Aug; 29(4):117-120. PubMed ID: 38700147 [TBL] [Abstract][Full Text] [Related]
19. A myelin-related transcriptomic profile is shared by Pitt-Hopkins syndrome models and human autism spectrum disorder. Phan BN; Bohlen JF; Davis BA; Ye Z; Chen HY; Mayfield B; Sripathy SR; Cerceo Page S; Campbell MN; Smith HL; Gallop D; Kim H; Thaxton CL; Simon JM; Burke EE; Shin JH; Kennedy AJ; Sweatt JD; Philpot BD; Jaffe AE; Maher BJ Nat Neurosci; 2020 Mar; 23(3):375-385. PubMed ID: 32015540 [TBL] [Abstract][Full Text] [Related]
20. A case of Pitt-Hopkins syndrome with absence of hyperventilation. Inati A; Abbas HA; Korjian S; Daaboul Y; Harajeily M; Saab R J Child Neurol; 2013 Dec; 28(12):1698-701. PubMed ID: 23248353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]